Company Code: 6541 Company Name: Tanvex-KY Industry: Biotechnology and Medical Care Data Period: 2026-02 Monthly Revenue: 22,721 thousand (0.23 billion) Year-on-Year Change: +218.7%
FACT BOX
- Source: PR Times
- Category: 其他
其他
[Tanvex-KY] February 2026 Revenue Reaches 0.23 Billion (YoY +218.7%)
Citation-Grade
Primary-source linked
Schema.org verified
NQ 63 / 100
Published Feb 1, 2026 9:00 AM ・ Updated Jun 1, 2026 12:17 PM ・ 2 min read ・ Source: PR Times
Show contents
⚡ Key Points
- Tanvex-KY has announced its impressive revenue report for February 2026.
- The company's revenue for the month was 0.23 billion, a surge of 218.7% compared to the same period last year.
- This figure indicates that the biotechnology and healthcare company has made significant progress in the biosimilar market.
Tanvex-KY has announced its impressive revenue report for February 2026. The company's revenue for the month was 0.23 billion, a surge of 218.7% compared to the same period last year. This figure indicates that the biotechnology and healthcare company has made significant progress in the biosimilar market.
Editorial & Verification Standards
The Washin AI News desk structures and reviews this article under the following standards.
- Start only from primary sources (official PR, disclosures, wire services)
- Numbers and proper nouns machine-checked against the source (number-completeness check)
- Company names and tickers verified via registry (Registry/TWSE/Wikidata)
- No speculation; nothing stated that is not in the source
Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›
- Announced Feb 1, 2026 9:00 AM — Distributor PR Times
- Collected Apr 7, 2026 8:00 AM
- AI structured & analyzed Apr 8, 2026 12:19 AM
- Desk-reviewed & published Feb 1, 2026 9:00 AM
FAQ
What are the key facts in this article?
Tanvex-KY has announced its impressive revenue report for February 2026. The company's revenue for the month was 0.23 billion, a surge of 218.7% compared to the same period last year. This figure indicates that the biotechnology and healthcare company has made significant progress in the biosimilar market.
Where is the primary source?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6541-11502
When was it published?
Feb 1, 2026
Cite this article — HOW TO CITE
Washin AI News Desk“[Tanvex-KY] February 2026 Revenue Reaches 0.23 Billion (YoY +218.7%)”AI News by Washin Village（和心村）, Feb 1, 2026. https://aeo.washinmura.jp/ai/%E6%B3%B0%E7%A6%8F-ky/en/news/2026-02-01-tanvex-ky-february-2026-revenue-reaches
AI CRAWLER ACTIVITY
as of Jul 17, 2026
AI crawler visits to this article (cumulative)212 bots
Site-wide cumulative
Applebot
bot_visits_summary
4136k
last Jul 17, 2026
ClaudeBot
bot_visits_summary
3024k
last Jul 17, 2026
GPTBot
bot_visits_summary
2585k
last Jul 17, 2026
Bingbot
bot_visits_summary
2449k
last Jul 17, 2026
Meta AI
bot_visits_summary
1011k
last Jul 17, 2026
Google AI
bot_visits_summary
687k
last Jul 17, 2026
※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.
Washin AI News（AI News by Washin Village（和心村））
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.
Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →